Further modifications of the modular characterized scaffolds generate a devices suitable for local release of growth factors leading to improved wound healing. Patients presenting with large wounds, e.g. diabetic foot or MRSA infections, will have a greater chance of healing due to new vessel formation near the site of infection. The InfectoStent scaffolds support existing therapies by improving the efficacy of systemically administered compounds. This type of therapy helps to lower the health care costs during hospitalization and reduces the discomfort of the patients related to repeated wound disinfections.
